Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Zembutsu

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Oncotarget|April 20, 2017
Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancerHiroaki Taniguchi, Daisuke Hoshino, Chiharu Moriya, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Identification of novel molecular markers for detection of gastric cancer cells in the peripheral blood circulation using genome-wide microarray analysisNobuyuki Matsumura, Hitoshi Zembutsu, Koji Yamaguchi, et al.
Plos One|September 28, 2020
Whole-exome sequencing of 79 xenografts as a potential approach for the identification of genetic variants associated with sensitivity to cytotoxic anticancer drugsChihiro Udagawa, Yasushi Sasaki, Yasuhiro Tanizawa, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Predicting response of bladder cancers to gemcitabine and carboplatin neoadjuvant chemotherapy through genome-wide gene expression profilingYoichiro Kato, Hitoshi Zembutsu, Ryo Takata, et al.
International Journal of Oncology|June 7, 2003
Gene-expression profiles of human tumor xenografts in nude mice treated orally with the EGFR tyrosine kinase inhibitor ZD1839Hitoshi Zembutsu, Yasuyuki Ohnishi, Yataro Daigo, et al.
International Journal of Oncology|January 17, 2009
Predicting response to docetaxel neoadjuvant chemotherapy for advanced breast cancers through genome-wide gene expression profilingHitoshi Zembutsu, Yasuyo Suzuki, Aya Sasaki, et al.
Pharmacogenetics and Genomics|July 30, 2011
Genome-wide association study of epirubicin-induced leukopenia in Japanese patientsYuvaraj Srinivasan, Mitsunori Sasa, Junko Honda, et al.
Cancer Science|February 26, 2008
Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapyKazuma Kiyotani, Taisei Mushiroda, Mitsunori Sasa, et al.
Cancer Research|February 28, 2002
An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell linesShingo Dan, Tatsuhiko Tsunoda, Osamu Kitahara, et al.
Journal of Hepato-Biliary-Pancreatic Surgery|July 22, 2006
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical featuresNoriko Nishikawa, Yasutoshi Kimura, Kenji Okita, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Oncotarget|April 20, 2017
Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancerHiroaki Taniguchi, Daisuke Hoshino, Chiharu Moriya, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Identification of novel molecular markers for detection of gastric cancer cells in the peripheral blood circulation using genome-wide microarray analysisNobuyuki Matsumura, Hitoshi Zembutsu, Koji Yamaguchi, et al.
Plos One|September 28, 2020
Whole-exome sequencing of 79 xenografts as a potential approach for the identification of genetic variants associated with sensitivity to cytotoxic anticancer drugsChihiro Udagawa, Yasushi Sasaki, Yasuhiro Tanizawa, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Predicting response of bladder cancers to gemcitabine and carboplatin neoadjuvant chemotherapy through genome-wide gene expression profilingYoichiro Kato, Hitoshi Zembutsu, Ryo Takata, et al.
International Journal of Oncology|June 7, 2003
Gene-expression profiles of human tumor xenografts in nude mice treated orally with the EGFR tyrosine kinase inhibitor ZD1839Hitoshi Zembutsu, Yasuyuki Ohnishi, Yataro Daigo, et al.
International Journal of Oncology|January 17, 2009
Predicting response to docetaxel neoadjuvant chemotherapy for advanced breast cancers through genome-wide gene expression profilingHitoshi Zembutsu, Yasuyo Suzuki, Aya Sasaki, et al.
Pharmacogenetics and Genomics|July 30, 2011
Genome-wide association study of epirubicin-induced leukopenia in Japanese patientsYuvaraj Srinivasan, Mitsunori Sasa, Junko Honda, et al.
Cancer Science|February 26, 2008
Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapyKazuma Kiyotani, Taisei Mushiroda, Mitsunori Sasa, et al.
Cancer Research|February 28, 2002
An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell linesShingo Dan, Tatsuhiko Tsunoda, Osamu Kitahara, et al.
Journal of Hepato-Biliary-Pancreatic Surgery|July 22, 2006
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical featuresNoriko Nishikawa, Yasutoshi Kimura, Kenji Okita, et al.
Pageof 8